<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373823/bin/thnov12p5615g005.jpg"/> </div> <div class="text-side"> <h1>Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma.</h1> <p>Histology and immunohistochemistry of xenografts. Immunohistochemical staining of tumor sections revealed specific uptake of [64Cu]Cu-DOTAGA-ch14.18/CHO in NBs 48 h after tracer injection (A). After injection of [64Cu]Cu-DOTAGA-ch14.18/CHO into NB-bearing animals, tumors showed clearly positive staining (left panel). Controls (GD2-negative tumors; ctrl and control antibody; ab) showed only a slight background signal (middle and right panels). H&amp;E staining of CHP-134 and HEK-293 lesions revealed large cells with irregular nuclei, open chromatin and prominent nucleoli. CD31 immunostaining indicated blood vessels of variable caliber in both xenografts (B).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35966592/" target="_blank">35966592</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>